134 related articles for article (PubMed ID: 6088033)
1. Virus-augmented delayed hypersensitivity skin tests in gynecological malignancies.
Freedman RS; Bowen JM; Atkinson EN; Scott W; Wagner S
Cancer Immunol Immunother; 1984; 17(2):142-6. PubMed ID: 6088033
[TBL] [Abstract][Full Text] [Related]
2. Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells.
Savage HE; Rossen RD; Hersh EM; Freedman RS; Bowen JM; Plager C
Cancer Res; 1986 Apr; 46(4 Pt 2):2127-33. PubMed ID: 3948184
[TBL] [Abstract][Full Text] [Related]
3. Cellular hypersensitivity in patients with squamous cell carcinoma of the cervix.
Chen SS; Koffler D; Cohen CJ
Am J Obstet Gynecol; 1975 Jan; 121(1):91-5. PubMed ID: 1115121
[TBL] [Abstract][Full Text] [Related]
4. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
Wells SA; Melewicz FC; Christiansen C; Ketcham AS
Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
[No Abstract] [Full Text] [Related]
5. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
[No Abstract] [Full Text] [Related]
6. Delayed cutaneous hypersensitivity reactions to melanoma antigen.
Holmes EC; Roth JA; Morton DL
Surgery; 1975 Aug; 78(2):160-4. PubMed ID: 1154259
[TBL] [Abstract][Full Text] [Related]
7. Immunologic response in gynecologic malignancy as demonstrated by the delayed hypersensitivity reaction: clinical correlations.
Nalick RH; DiSaia PJ; Rea TH; Morrow MH
Am J Obstet Gynecol; 1974 Feb; 118(3):393-405. PubMed ID: 4358924
[No Abstract] [Full Text] [Related]
8. Cellular hypersensitivity in patients with adenomatous hyperplasia and adenocarcinoma of the endometrium.
Chen SY; Cohen CJ; Koffler D
Am J Obstet Gynecol; 1976 Oct; 126(3):370-3. PubMed ID: 986771
[TBL] [Abstract][Full Text] [Related]
9. Immunological aspects of gynecological malignancies.
DiSaia PJ
J Reprod Med; 1975 Jan; 14(1):17-20. PubMed ID: 1110478
[TBL] [Abstract][Full Text] [Related]
10. Relation of cell-mediated immunity in women with genital tract cancer to origin, histology, clinical stage and subsequent behaviour of neoplasm.
Khoo SK; Mackay EV
J Obstet Gynaecol Br Commonw; 1974 Mar; 81(3):229-35. PubMed ID: 4821482
[No Abstract] [Full Text] [Related]
11. Tumor-associated antigens in gynecologic cancer.
DiSaia PJ
Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
[TBL] [Abstract][Full Text] [Related]
12. A review of tumor antigens in gynecologic malignancies.
Gall SA
J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
[TBL] [Abstract][Full Text] [Related]
13. Unblocking or activation of the cellular immune mechanism by induced proteolysis in patients with cancer.
Thornes RD
Lancet; 1974 Aug; 2(7877):382-4. PubMed ID: 4137344
[No Abstract] [Full Text] [Related]
14. Immunocompetence and prognosis in patients with gynecologic cancer.
Nalick RH; Disaia PJ; Rea TH; Morrow CP
Gynecol Oncol; 1974 Apr; 2(1):81-92. PubMed ID: 4459211
[No Abstract] [Full Text] [Related]
15. Cellular immunologic responsiveness to extracts of ovarian epithelial tumors.
Melnick H; Barber HR
Gynecol Oncol; 1975 Mar; 3(1):77-86. PubMed ID: 168133
[No Abstract] [Full Text] [Related]
16. Breast cancer skin test antigens of increased sensitivity prepared from vesicular stomatitis virus-infected tumor cells.
Austin FC; Boone CW; Levin DL; Cavins JA; Djerassi I; Rosner D; Case R; Klein E
Cancer; 1982 May; 49(10):2034-42. PubMed ID: 6280832
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immune reaction to two gynecologic malignant tumors.
DiSala PJ; Rutledge FN; Smith JP; Sinkovics JG
Cancer; 1971 Nov; 28(5):1129-37. PubMed ID: 5125661
[No Abstract] [Full Text] [Related]
18. Delayed cutaneous hypersensitivity reactions to tumor extracts in patients with cervical carcinoma.
Melewicz FC; Wells SA; Christiansen C; Ketcham A
Surg Forum; 1972; 23(0):94-6. PubMed ID: 4671036
[No Abstract] [Full Text] [Related]
19. [Clinical evaluation of specificity of serum CA125 as a tumor marker of ovarian carcinoma].
Iwasaka T; Ohkuma Y; Yoshimura T; Sugimori H
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):917-23. PubMed ID: 2426378
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
Ueda G; Inoue Y; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Saito J; Nishino T; Abe Y
Int J Gynecol Pathol; 1984; 3(3):291-8. PubMed ID: 6389386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
